Admission Date:  [**2104-12-23**]              Discharge Date:   [**2104-12-28**]  Date of Birth:  [**2038-6-16**]             Sex:   M  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 2297**] Chief Complaint: hypotension, low Hct  Major Surgical or Invasive Procedure: EGD IR embolization  History of Present Illness: This is a 66 yo male with h/o metastatic bladder ca to liver, lung on chemo who originally presented on [**2104-12-23**] from clinic with hypotension and Hct of 17.
Pt was having episodes of syncope at home and some abdominal pain, went to his outpt oncologist's office for chemotherapy (C1D8 Gemcitabine/Cisplatin) where he was noted to have a BP of 75/56 and Hct was 17 and thus pt was sent to the ED.
CT abd showed pneumobilia [**12-17**] cholecystoenteric fistula.
GI has been following who performed an EGD which showed ulcers in stomach and duodenal bulb as well as a larger ulcerated region at the junction of duodenal bulb and second part of duodenum on the posterior wall of the duodenum with adherent clot, suggestive of possible tumor eroding the small bowel wall.
Per GI recs, pt was continued on PPI gtt and blood transfusions.
Currently, Hct is 21.2 and getting 2U pRBCs.
Past Medical History: ONCOLOGIC HISTORY: - [**6-/2104**] pt referred to Dr [**First Name (STitle) **] for microscopic hematuria, found to have abnormal digital rectal exam with nodularity adjacent to the right prostate and the right seminal vesicle - [**2104-7-22**] cystoscopy showed normal bladder mucosa except for >2 cm calculus protruding from a diverticulum between the right urothelial orifice and bladder neck.
- [**2104-9-11**] prostate biopsy showed invasive high-grade carcinoma involving the prostatic stroma and extraprostatic adipose tissue, one core showed prostatic adenocarcinoma, [**Doctor Last Name **] score 3+3.
- [**2104-10-16**] cystoprostatectomy and ileal conduit.The final pathology examination showed invasive urothelial (transitional cell) carcinoma arising from the bladder diverticulum and extending into the perivesicular adipose tissue, prostate gland and right seminal vesicle.
A [**Doctor Last Name **] 3+3 adenocarcinoma of the prostate was identified, as well.
Nephrolithiasis 2.
Pertinent Results: [**2104-12-27**] 05:47AM BLOOD Hct-22.5* [**2104-12-27**] 02:00AM BLOOD WBC-4.3 RBC-2.85*# Hgb-8.9*# Hct-24.4* MCV-86 MCH-31.1 MCHC-36.3* RDW-14.9 Plt Ct-96* [**2104-12-26**] 10:14PM BLOOD Hct-26.7*# [**2104-12-26**] 05:06PM BLOOD Hct-20.9* [**2104-12-26**] 02:10PM BLOOD Hct-26.3* [**2104-12-26**] 09:27AM BLOOD WBC-4.8 RBC-4.15*# Hgb-12.2*# Hct-34.0*# MCV-82 MCH-29.3 MCHC-35.8* RDW-14.7 Plt Ct-109* [**2104-12-26**] 03:41AM BLOOD WBC-5.1 RBC-2.61* Hgb-7.7*# Hct-21.3* MCV-82 MCH-29.7 MCHC-36.3* RDW-14.0 Plt Ct-80* [**2104-12-25**] 08:39PM BLOOD Hct-21.2* [**2104-12-25**] 03:53PM BLOOD Hct-22.4* Plt Ct-145*# [**2104-12-25**] 08:26AM BLOOD Hct-22.8* Plt Ct-70* [**2104-12-25**] 01:45AM BLOOD WBC-10.0 RBC-3.38*# Hgb-10.3*# Hct-28.5* MCV-84 MCH-30.6 MCHC-36.3* RDW-14.3 Plt Ct-63* [**2104-12-24**] 11:01PM BLOOD Hct-29.6*# [**2104-12-24**] 07:15PM BLOOD Hct-22.3* [**2104-12-24**] 01:44PM BLOOD Hct-21.4* [**2104-12-24**] 07:23AM BLOOD Hct-28.3* [**2104-12-24**] 03:59AM BLOOD Hct-28.9*# [**2104-12-23**] 10:45PM BLOOD WBC-11.5* RBC-2.65* Hgb-7.9* Hct-22.0* MCV-83 MCH-29.9 MCHC-36.1* RDW-15.2 Plt Ct-108* [**2104-12-23**] 06:15PM BLOOD WBC-8.8 RBC-2.68*# Hgb-8.0*# Hct-22.5*# MCV-84 MCH-29.7 MCHC-35.5* RDW-14.7 Plt Ct-105* [**2104-12-23**] 12:25PM BLOOD WBC-8.9 RBC-1.98* Hgb-5.9* Hct-17.1* MCV-86 MCH-29.8 MCHC-34.5 RDW-14.4 Plt Ct-124* [**2104-12-23**] 10:46AM BLOOD WBC-10.4# RBC-2.30*# Hgb-6.6*# Hct-20.6*# MCV-90 MCH-28.7 MCHC-32.1 RDW-14.1 Plt Ct-154# [**2104-12-26**] 09:27AM BLOOD PT-15.1* PTT-24.5 INR(PT)-1.3* [**2104-12-26**] 03:41AM BLOOD PT-19.9* PTT-27.1 INR(PT)-1.8* [**2104-12-25**] 01:45AM BLOOD PT-15.0* PTT-22.7 INR(PT)-1.3* [**2104-12-24**] 03:59AM BLOOD PT-13.7* PTT-23.5 INR(PT)-1.2* [**2104-12-23**] 12:25PM BLOOD PT-13.4 PTT-19.6* INR(PT)-1.1 [**2104-12-24**] 03:59AM BLOOD Fibrino-515* [**2104-12-27**] 02:00AM BLOOD Glucose-623* UreaN-63* Creat-1.6* Na-134 K-3.9 Cl-110* HCO3-16* AnGap-12 [**2104-12-26**] 03:41AM BLOOD Glucose-212* UreaN-72* Creat-1.7* Na-148* K-4.5 Cl-120* HCO3-19* AnGap-14 [**2104-12-25**] 01:45AM BLOOD Glucose-114* UreaN-66* Creat-1.3* Na-146* K-4.2 Cl-116* HCO3-21* AnGap-13 [**2104-12-24**] 03:59AM BLOOD Glucose-112* UreaN-59* Creat-1.3* Na-140 K-3.3 Cl-108 HCO3-22 AnGap-13 [**2104-12-23**] 10:46AM BLOOD UreaN-65* Creat-1.6* Na-130* K-4.1 Cl-91* HCO3-29 AnGap-14 [**2104-12-26**] 03:41AM BLOOD ALT-14 AST-18 LD(LDH)-153 AlkPhos-28* TotBili-0.5 [**2104-12-23**] 10:46AM BLOOD ALT-30 AST-26 LD(LDH)-128 AlkPhos-79 TotBili-0.4 DirBili-0.2 IndBili-0.2 [**2104-12-27**] 02:00AM BLOOD Calcium-5.5* Phos-3.8 Mg-1.6 [**2104-12-26**] 03:41AM BLOOD Calcium-6.1* Phos-4.8* Mg-2.0 [**2104-12-25**] 01:45AM BLOOD Calcium-7.0* Phos-4.5 Mg-2.4 [**2104-12-24**] 03:59AM BLOOD Calcium-7.0* Phos-3.6 Mg-1.9 [**2104-12-23**] 10:46AM BLOOD Albumin-2.7* Mg-2.1 [**2104-12-23**] 10:46AM BLOOD Hapto-357* [**2104-12-23**] 06:27PM BLOOD Lactate-1.0 [**2104-12-23**] 12:44PM BLOOD Lactate-2.4*  Micro: [**2104-12-24**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2104-12-23**] BLOOD CULTURE Blood Culture, Routine-PENDING  Imaging/Studies: [**12-23**] CXR: IMPRESSION: Relatively stable examination.
[**12-23**] CT abd/pelvis: IMPRESSION: 1.
[**12-25**] mesenteric angiogram with embolization of GDA  [**12-26**] GI bleed study: IMPRESSION: Bleeding in the region of duodenum, presumably in the GDA territory.
[**12-26**] mesenteric angiogram   Brief Hospital Course: This is a 66 yo male with h/o metastatic bladder ca to liver, lung on chemo who originally presented on [**2104-12-23**] from clinic with hypotension and Hct of 17, has been in SICU getting blood transfusions, then transferred to MICU for further management as pt is not a surgical candidate.
Continued to require blood transfusions.
Per IR recs, pt underwent a tagged RBC scan which showed active bleeding in GDA territory and pt underwent IR embolization again on [**2104-12-26**].
Medications on Admission: APREPITANT [EMEND] - 125 mg (1)-80 mg (1)-80 mg (1) Capsule, Dose Pack - 1 Capsule(s) by mouth daily the day of chemotherapy and the following 2 days CITALOPRAM - 10 mg Tablet - 1 Tablet(s) by mouth daily DEXAMETHASONE - 4 mg Tablet - 1 Tablet(s) by mouth every twelve (12) hours x 2 days after chemotherapy LORAZEPAM - 0.5 mg Tablet - [**11-16**] Tablet(s) by mouth daily as needed for anxiety or nausea LOVASTATIN - 20 mg Tablet - 1 Tablet(s) by mouth once a day ONDANSETRON - 8 mg Tablet, Rapid Dissolve - 1 Tablet(s) by mouth twice daily x2 days after chemo and as needed afterward PROCHLORPERAZINE MALEATE - 10 mg Tablet - 1 Tablet(s) by mouth every six (6) hours as needed for nausea ASPIRIN - 81 mg Tablet - 1 Tablet(s) by mouth once a day DOCUSATE SODIUM - 100 mg Capsule - 1 Capsule(s) by mouth twice a day as needed for constipation take this while taking narcotic pain medication, stop if you develop diarrhea POLYETHYLENE GLYCOL 3350 [MIRALAX] -  (Prescribed by Other Provider) - Dosage uncertain   Discharge Medications: N/A  Discharge Disposition: Expired  Discharge Diagnosis: Metastatic prostate ca  Discharge Condition: N/A  Discharge Instructions: N/A  Followup Instructions: N/A   Completed by:[**2104-12-28**
